Submitted by admin on September 13, 2019 - 11:05am
Amgen shares hit after analysts expose buried FDA trial halt
Biogen, Eisai throw out remaining Alzheimer's BACE hope
Roche looks to file subcutaneous breast cancer combo
Celgene's phase 3 AML test chalks up a win
*please scroll down for all the latest news*
Want to stay updated on CP happenings? New features, new boards, CP wire articles, and more? Click here to subscribe
